As of Sep 18
| -0.90 / -1.07%|
The 3 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 89.00, with a high estimate of 94.00 and a low estimate of 73.00. The median estimate represents a +7.42% increase from the last price of 82.85.
The current consensus among 4 polled investment analysts is to Buy stock in Magellan Health Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.